Editor’s Pick Sol Voltaics plans to begin production of nanotechnology that makes solar more efficient.
Nanotech Security, an anti-counterfeit technology company, raised $3.9 million for its “nano-optics” that are modeled after butterfly wings.
Editor’s Pick “We are trying to be the first to build the quantum computer,” says Crow. “When we do it, and we will do it eventually, it’s going to be bigger than the moon landing.”
Nanotechnology is starting to pay off in materials that enable colorful liquid crystal displays.
Researchers at the Department of Energy’s Argonne National Laboratory in Argonne, Ill., have found a way to assemble nanoparticles into larger structures, a technique that could accelerate the development of battery and bioenergy-based technologies.
Smart meter systems company Elster has filed for an IPO, offering 16.2 million initial shares that will be priced between $16 and $18. It is expected to net $152 million from the offering. As Green Tech Media notes, the company’s main business is in gas, and it hasn’t made significant headway into the advanced metering infrastructure business. The IPO would presumably to go pay off some of its debt.
NanoBioDesign, a London developer of systems that screen experimental drugs against key liver enzymes, raised $1 million (£500,000) to support manufacturing of its protein-chip devices. The funding was provided by the Imperial Innovations Group and the Capital Fund.
Tempo Pharmaceuticals, a Cambridge, Mass., developer of new-drug formulations, raised $12.1 million in a first funding round. The company, which touts itself as a “nanopharmaceutical” maker, aims to improve the safety and effectiveness of existing drugs using engineered nanoparticles designed to home in on particular organs or tissues, then release two or more drugs in sequence. Tempo initially plans to focus on cancer.